Exelixis, Inc. (EXEL)
41.39
+0.32
(+0.78%)
USD |
NASDAQ |
Dec 11, 16:00
41.36
-0.03
(-0.07%)
After-Hours: 20:00
Exelixis EPS Diluted (TTM): 2.375 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | -1.432 |
| ADMA Biologics, Inc. | 0.8515 |
| Aldeyra Therapeutics, Inc. | -0.7218 |
| Merck & Co., Inc. | 7.560 |
| ACADIA Pharmaceuticals, Inc. | 1.554 |